Elisabeth Solau‐Gervais

Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger et al. · JAMA · 2016 · 189 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

Bruno Fautrel, Thao Pham, Toni Alfaiate et al. · Annals of the Rheumatic Diseases · 2015 · 147 citations

Medicine, Immunology, Pharmacotherapy +16

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor-  Antagonists

Florence Tubach, Philippe Ravaud, Dominique Salmon‐Céron et al. · Clinical Infectious Diseases · 2006 · 143 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment

Maxime Bréban, Philippe Ravaud, Pascal Claudepierre et al. · Arthritis & Rheumatism · 2007 · 136 citations

Medicine, Clinical Sciences, Pharmacotherapy +11

Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature

Jean‐Marie Berthelot, Michel De Bandt, Philippe Goupille et al. · Joint Bone Spine · 2008 · 116 citations

Medicine, Immunology, Obstetrics +11